CGCanopy Growth Corporation CGC · NASDAQ
$0.71 -3.06% (-$0.02)
- Market cap
- $441.6M
- Enterprise value
- $382.3M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 1.4x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -10.5%
- Gross margin
- 25.5%
- Net margin
- -80.7%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 2.41
- Free float
- 99.4%
About the company
Canopy Growth Corporation (CGC) is one of the leading global producers and retailers of legal medical cannabis and related products. The company operates in various areas of the cannabis industry, including cultivation, processing, research, and the development of new products. Canopy Growth has its own brands offering a wide range of cannabinoid-containing products, including CBD and THC. The company also has strategic partnerships with pharmaceutical companies and invests in innovative cannabis-related projects. With its global reach and expansion into new markets, Canopy Growth holds a solid position in the cannabis market. Investing in Canopy Growth Corporation (CGC) shares can be an interesting choice for investors who follow the medical cannabis sector and seek a company with potential for growth in the growing industry.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Luc Mongeau
Employees
1,128
Headquarters
Smiths Falls
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number